A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Abstract Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific antigen (PSA) responses, accumulating c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Srikanth Boinapally, Hye-Hyun Ahn, Bei Cheng, Mary Brummet, Hwanhee Nam, Kathleen L. Gabrielson, Sangeeta R. Banerjee, Il Minn, Martin G. Pomper
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/66509369cb3640a3b49a1ee996b47027
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares